Search

everythinglearnresearchcommunity

for

Search:↓

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Proper education can prevent traction alopecia in women of color.

Human hair follicles can regenerate and recover after severe injury by going through a brief abnormal resting phase before growing again.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Personalized treatment plans are important for people with alopecia areata.

Mice with autoimmune hair loss showed signs of heart problems.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Sildenafil, often used for erectile dysfunction, may help hair growth.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.